Knopp Biosciences

About:

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

Website: http://knoppbio.com

Twitter/X: KnoppBio/

Top Investors: Biogen, Innovation Works, Solas BioVentures, Saturn Partners, LaunchCyte

Description:

Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families. Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Total Funding Amount:

$164M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2004-01-01

Contact Email:

contact(AT)knoppbio.com

Founders:

Gregory Hebrank, Robert Bowser Ph.D.

Number of Employees:

1-10

Last Funding Date:

2020-11-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai